SARS-CoV-2 vaccine efficacy testing is now facing increasing challenges in the face of an ongoing pandemic with the emergence of new variants and waning vaccine immunity. Evidence supports the ...
In the cohort that received the BA.5-containing bivalent booster, the neutralizing activity against all the omicron subvariants as compared with that against WA1/2020 was better than in the other two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results